ICAM1 and systemic sclerosis: Although a number of previous publications have shown binding of SSc sera to the cell surface or to cytoplasmic targets of HUVEC this is the first direct demonstration that one of the antibodies produced is against the 90 kDa adhesion molecule ICAM-1.